Published in J Virol on August 01, 1985
Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol (1990) 3.63
Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc Natl Acad Sci U S A (1986) 3.28
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol (1986) 2.65
Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J Virol (1989) 2.35
Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J Virol (2004) 2.27
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol (1993) 2.01
Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol (1992) 1.79
Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J Virol (1997) 1.72
Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol (1996) 1.61
The control of herpes simplex virus type-1 late gene transcription: a 'TATA-box'/cap site region is sufficient for fully efficient regulated activity. Nucleic Acids Res (1986) 1.58
Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J Virol (1998) 1.52
Expression of herpes simplex virus type 1 major DNA-binding protein, ICP8, in transformed cell lines: complementation of deletion mutants and inhibition of wild-type virus. J Virol (1987) 1.51
Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme. J Virol (2002) 1.43
Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. J Virol (1991) 1.43
Conservation of gene organization in the lymphotropic herpesviruses herpesvirus Saimiri and Epstein-Barr virus. J Virol (1988) 1.42
The herpes simplex virus UL37 protein is phosphorylated in infected cells. J Virol (1993) 1.41
Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J Virol (1990) 1.35
Characterization of a major DNA-binding domain in the herpes simplex virus type 1 DNA-binding protein (ICP8). J Virol (1990) 1.35
Functional mapping of Autographa california nuclear polyhedrosis virus genes required for late gene expression. J Virol (1988) 1.26
Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J Virol (1988) 1.15
Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells. J Virol (1987) 1.12
DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1. Nucleic Acids Res (1986) 1.06
Regulation of transcription in vitro from herpes simplex virus genes. J Virol (1986) 1.06
The use of beta-galactosidase as a marker gene to define the regulatory sequences of the herpes simplex virus type 1 glycoprotein C gene in recombinant herpesviruses. Nucleic Acids Res (1988) 0.99
Human cytomegalovirus UL44 concentrates at the periphery of replication compartments, the site of viral DNA synthesis. J Virol (2011) 0.98
Mammalian alphaherpesvirus miRNAs. Biochim Biophys Acta (2011) 0.93
Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One (2011) 0.90
A dominant-negative herpesvirus protein inhibits intranuclear targeting of viral proteins: effects on DNA replication and late gene expression. J Virol (2000) 0.88
Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175. J Virol (1991) 0.86
Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication. J Virol (2012) 0.86
Identification of a region of the herpes simplex virus single-stranded DNA-binding protein involved in cooperative binding. J Virol (1998) 0.86
Surface lysine and tyrosine residues are required for interaction of the major herpes simplex virus type 1 DNA-binding protein with single-stranded DNA. J Virol (1992) 0.81
The promoter for the late gene encoding Vp5 of herpes simplex virus type 1 is recognized by cell extracts derived from uninfected cells. J Virol (1986) 0.79
Visualizing the replicating HSV-1 virus using STED super-resolution microscopy. Virol J (2016) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell (1977) 61.24
Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem (1975) 56.72
Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels. J Mol Biol (1977) 33.84
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol (1974) 26.25
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J Virol (1976) 8.73
A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature (1980) 8.47
Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol (1979) 7.53
Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell (1984) 5.30
T antigen repression of SV40 early transcription from two promoters. Cell (1981) 4.83
Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol (1983) 4.56
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species. Virology (1980) 4.05
Genetic analysis of temperature-sensitive mutants which define the gene for the major herpes simplex virus type 1 DNA-binding protein. J Virol (1983) 3.98
Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J Mol Biol (1981) 3.18
Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus. J Virol (1982) 2.99
Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species. J Virol (1981) 2.97
Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1. J Virol (1980) 2.94
Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation. J Virol (1975) 2.92
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J Virol (1984) 2.84
Anatomy of herpes simplex virus DNA VIII. Properties of the replicating DNA. J Virol (1977) 2.57
The stability of early adenovirus mRNA is controlled by the viral 72 kd DNA-binding protein. Cell (1981) 2.44
gamma 2-Thymidine kinase chimeras are identically transcribed but regulated a gamma 2 genes in herpes simplex virus genomes and as beta genes in cell genomes. Mol Cell Biol (1985) 2.44
Regulation of early adenovirus transcription: a protein product of early region 2 specifically represses region 4 transcription. Proc Natl Acad Sci U S A (1980) 2.42
An adenovirus type 5 gene function required for initiation of viral DNA replication. Virology (1975) 2.40
Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro. Proc Natl Acad Sci U S A (1976) 2.36
Complex regulation of simian virus 40 early-region transcription from different overlapping promoters. Mol Cell Biol (1984) 2.28
Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro. Antimicrob Agents Chemother (1977) 2.28
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Mol Cell Biol (1983) 2.15
Characterization of the major mRNAs transcribed from the genes for glycoprotein B and DNA-binding protein ICP8 of herpes simplex virus type 1. J Virol (1984) 1.99
Mutations in the major DNA-binding protein gene of herpes simplex virus type 1 result in increased levels of viral gene expression. J Virol (1983) 1.98
Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer. J Virol (1979) 1.97
The synthesis of herpes simplex virus proteins in the absence of virus DNA synthesis. Biochem Biophys Res Commun (1975) 1.95
Thermolabile in vivo DNA-binding activity associated with a protein encoded by mutants of herpes simplex virus type 1. J Virol (1983) 1.86
Characterization of two conformational forms of the major DNA-binding protein encoded by herpes simplex virus 1. J Virol (1982) 1.75
Inhibition of adenovirus early region IV transcription in vitro by a purified viral DNA binding protein. Nature (1983) 1.56
Transactivation of a late herpes simplex virus promoter. Mol Cell Biol (1984) 1.53
An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8. J Virol (1985) 1.37
Nuclear localization of herpesvirus proteins: potential role for the cellular framework. Mol Cell Biol (1983) 1.34
Purification and molecular characterization of adenovirus type 2 DNA-binding protein. J Virol (1977) 1.33
Repair replication in human cells studied by sodium iodide isopycnic centrifugation of DNA in a fixed-angle rotor. Anal Biochem (1973) 1.16
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells. J Virol (1979) 8.05
Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol (2001) 6.62
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (1998) 6.49
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol Cell Biol (1985) 5.76
The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication. Cell (1984) 4.90
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol (1989) 4.85
Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell (1986) 4.66
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
Molecular genetics of herpes simplex virus: demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion. Proc Natl Acad Sci U S A (1978) 4.31
Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science (1988) 4.16
Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol (2001) 4.13
Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. J Virol (1977) 4.03
Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol (2000) 3.96
Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol (1990) 3.63
Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature (1987) 3.42
Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1977) 3.30
Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc Natl Acad Sci U S A (1986) 3.28
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. J Virol (1987) 3.24
Localization of two cellular forms of the vesicular stomatitis viral glycoprotein. J Virol (1977) 3.20
Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell (1988) 3.13
Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27. J Virol (1988) 3.08
Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus. J Virol (1982) 2.99
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
Molecular genetics of herpes simplex virus. VI. Characterization of a temperature-sensitive mutant defective in the expression of all early viral gene products. J Virol (1981) 2.52
Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J Virol (1989) 2.35
A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol (1997) 2.35
Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science (1987) 2.33
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol (2000) 2.16
RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J (1994) 2.04
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol (1993) 2.01
Herpes simplex virus alpha protein ICP27 can inhibit or augment viral gene transactivation. Virology (1989) 1.99
Characterization of the major mRNAs transcribed from the genes for glycoprotein B and DNA-binding protein ICP8 of herpes simplex virus type 1. J Virol (1984) 1.99
The toll of innate immunity on microbial pathogens. N Engl J Med (1999) 1.98
Mutations in the major DNA-binding protein gene of herpes simplex virus type 1 result in increased levels of viral gene expression. J Virol (1983) 1.98
Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer. J Virol (1979) 1.97
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A (1997) 1.89
Thermolabile in vivo DNA-binding activity associated with a protein encoded by mutants of herpes simplex virus type 1. J Virol (1983) 1.86
Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology (1998) 1.86
Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model. Virology (2000) 1.82
On the structure, functional equivalence, and replication of the four arrangements of herpes simplex virus DNA. Cold Spring Harb Symp Quant Biol (1979) 1.80
Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J Virol (1991) 1.79
Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures. J Virol (1996) 1.78
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
A mutant herpesvirus protein leads to a block in nuclear localization of other viral proteins. Mol Cell Biol (1986) 1.75
Characterization of two conformational forms of the major DNA-binding protein encoded by herpes simplex virus 1. J Virol (1982) 1.75
Molecular genetics of herpes simplex virus: the terminal a sequences of the L and S components are obligatorily identical and constitute a part of a structural gene mapping predominantly in the S component. Proc Natl Acad Sci U S A (1979) 1.73
Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene (1997) 1.70
Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J (1992) 1.68
Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J Virol (1994) 1.65
Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol (1999) 1.63
Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol (1996) 1.61
Assembly of herpes simplex virus replication proteins at two distinct intranuclear sites. Virology (1997) 1.60
The acidic amino-terminal region of herpes simplex virus type 1 alpha protein ICP27 is required for an essential lytic function. J Virol (1993) 1.59
Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activities. J Virol (1989) 1.59
Correct intranuclear localization of herpes simplex virus DNA polymerase requires the viral ICP8 DNA-binding protein. J Virol (1991) 1.55
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Proc Natl Acad Sci U S A (1999) 1.54
Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2. J Virol (2000) 1.53
Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J Virol (1998) 1.52
Characterization of herpes simplex virus 2 temperature-sensitive mutants whose lesions map in or near the coding sequences for the major DNA-binding protein. J Virol (1983) 1.51
Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol (1999) 1.51
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47
Comparison of the intranuclear distributions of herpes simplex virus proteins involved in various viral functions. Virology (1998) 1.46
Genetic identification of a portion of the herpes simplex virus ICP8 protein required for DNA-binding. Virology (1988) 1.45
Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci (1996) 1.45
Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J Virol (1994) 1.42
Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology (2000) 1.42
In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology (1994) 1.38
An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8. J Virol (1985) 1.37
Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J Virol (1990) 1.35
Humoral response to herpes simplex virus is complement-dependent. Proc Natl Acad Sci U S A (1999) 1.35
Nuclear localization of herpesvirus proteins: potential role for the cellular framework. Mol Cell Biol (1983) 1.34
Herpes simplex virus infection blocks events in the G1 phase of the cell cycle. Virology (2000) 1.31
Distal protein sequences can affect the function of a nuclear localization signal. Mol Cell Biol (1992) 1.31
Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells. Gene Ther (2003) 1.31
Membrane assembly: synthesis and intracellular processing of the vesicular stomatitis viral glycoprotein. J Supramol Struct (1977) 1.27
Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells. Virology (2001) 1.27
Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology (1996) 1.26
Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J Virol (1992) 1.26
Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Virology (1997) 1.23
Association between the herpes simplex virus major DNA-binding protein and alkaline nuclease. J Virol (1992) 1.23
Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J Comp Neurol (1994) 1.21
Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J Cell Biol (1996) 1.19
Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication. J Virol (1996) 1.17
Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol (1996) 1.17
Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J Immunol (2001) 1.16
Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci U S A (1992) 1.14
Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J Virol (1993) 1.13
Mechanism of virus-induced Ig subclass shifts. J Immunol (1994) 1.12
Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells. J Virol (1987) 1.12
rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. J Biol Chem (1994) 1.11
Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Virology (2001) 1.09